CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Hisamitsu Pharmaceutical Co Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Hisamitsu Pharmaceutical Co Inc
30F, Marunouchi Bldg., 2-4-1, Marunouchi
Phone: +81 352931700p:+81 352931700 CHIYODA-KU, TKY  100-6221  Japan Ticker: 45304530
Business Summary
Hisamitsu Pharmaceutical Co Inc is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the manufacture, sale and supply of pharmaceuticals and related products, and the operation of over-the-counter drug (OTC) business. It is also engaged in the manufacture and sale of drugs in the United States, Brazil, Vietnam, and Indonesia, the development work in Europe, the drug marketing and sales in China and Hong Kong. It is also engaged in the urban cable television broadcasting business, Internet connection service business, non-life insurance agency business, advertising agency business and the purchase, manufacture and sale of packing materials.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
2/29/20242/28/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
4833 Television broadcasting stations
4813 Telephone communications, except radiotelephone
6411 Insurance agents, brokers, and service
7941 Professional sports clubs and promoters
7311 Advertising agencies
5085 Industrial supplies

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Representative Director KazuhideNakatomi 50 5/1/2019 5/25/2007
Executive Officer, Chief Director of Main BU Unit, Director of Finance Unit YasuyukiMasuya 5/26/2022 5/26/2022
Senior Managing Director, Executive Officer KosukeSugiyama 71 5/1/2016 5/1/1999
10 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Noven Pharmaceuticals, Inc. 11960 S.W. 144th Street Miami FL United States

Business Names
Business Name
4530
HISAMITSU PHARMACEUTICAL CO., INC.
Hisamitsu Pharmaceutical Co., Ltd.
Hisamitsu U.S., Inc.
Northstar Merger Sub,Inc.
Noven Pharmaceuticals, Inc.

General Information
Number of Employees: 2,769 (As of 2/28/2023)
Outstanding Shares: 75,743,114 (As of 2/29/2024)
Shareholders: 8,250
Stock Exchange: TYO
Fax Number: +81 352931750


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 19, 2024